Your browser doesn't support javascript.
loading
Lineage-specific roles of the cytoplasmic polyadenylation factor CPEB4 in the regulation of melanoma drivers.
Pérez-Guijarro, Eva; Karras, Panagiotis; Cifdaloz, Metehan; Martínez-Herranz, Raúl; Cañón, Estela; Graña, Osvaldo; Horcajada-Reales, Celia; Alonso-Curbelo, Direna; Calvo, Tonantzin G; Gómez-López, Gonzalo; Bellora, Nicolas; Riveiro-Falkenbach, Erica; Ortiz-Romero, Pablo L; Rodríguez-Peralto, José L; Maestre, Lorena; Roncador, Giovanna; de Agustín Asensio, Juan C; Goding, Colin R; Eyras, Eduardo; Megías, Diego; Méndez, Raúl; Soengas, María S.
Affiliation
  • Pérez-Guijarro E; Melanoma Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
  • Karras P; Melanoma Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
  • Cifdaloz M; Melanoma Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
  • Martínez-Herranz R; Melanoma Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
  • Cañón E; Melanoma Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
  • Graña O; Bioinformatics Unit (CNIO), Madrid 28029, Spain.
  • Horcajada-Reales C; Department of Dermatology, Hospital Gregorio Marañón, Madrid 28003, Spain.
  • Alonso-Curbelo D; Melanoma Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
  • Calvo TG; Melanoma Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
  • Gómez-López G; Bioinformatics Unit (CNIO), Madrid 28029, Spain.
  • Bellora N; Department of Experimental and Health Sciences, Universidad Pompeu Fabra, Barcelona 08002, Spain.
  • Riveiro-Falkenbach E; Instituto de Investigación i+12, Hospital 12 de Octubre, Medical School, Universidad Complutense, Madrid 28041, Spain.
  • Ortiz-Romero PL; Instituto de Investigación i+12, Hospital 12 de Octubre, Medical School, Universidad Complutense, Madrid 28041, Spain.
  • Rodríguez-Peralto JL; Instituto de Investigación i+12, Hospital 12 de Octubre, Medical School, Universidad Complutense, Madrid 28041, Spain.
  • Maestre L; Monoclonal Antibodies Unit, Biotechnology Programme (CNIO), Madrid 28029, Spain.
  • Roncador G; Monoclonal Antibodies Unit, Biotechnology Programme (CNIO), Madrid 28029, Spain.
  • de Agustín Asensio JC; Department of Pediatric Surgery, Hospital Gregorio Marañón, Madrid 28003, Spain.
  • Goding CR; Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, Spain.
  • Eyras E; Department of Experimental and Health Sciences, Universidad Pompeu Fabra, Barcelona 08002, Spain.
  • Megías D; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona 08010, Spain.
  • Méndez R; Confocal Microscopy Unit, (CNIO) Madrid 28029, Spain.
  • Soengas MS; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona 08010, Spain.
Nat Commun ; 7: 13418, 2016 11 18.
Article de En | MEDLINE | ID: mdl-27857118

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protéines de liaison à l'ARN / Mélanome Type d'étude: Prognostic_studies Limites: Animals / Humans Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2016 Type de document: Article Pays d'affiliation: Espagne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protéines de liaison à l'ARN / Mélanome Type d'étude: Prognostic_studies Limites: Animals / Humans Langue: En Journal: Nat Commun Sujet du journal: BIOLOGIA / CIENCIA Année: 2016 Type de document: Article Pays d'affiliation: Espagne